Business
Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services
(TheNewswire) Toronto, Ontario - The Newswire - February 5, 2021 - Ve...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario - The Newswire -\nFebruary 5, 2021\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n ) (\n \n \n OTC:VPTDF) announces\n \n \n it has entered into an investor relations agreement with\nMarketSmart Communications Inc. pursuant to which MarketSmart will\nprovide investor relations (IR) services to Ventripoint. The IR\nagreement is for an initial term of six months commencing on February\n5\n \n \n th\n \n \n ,\n2021, with an option for renewal. Either party may terminate the\nagreement for any reason, with or without cause, on 15-days written\nnotice to the other.\n \n \n \n \n “\n \n \n We are looking forward to\nworking with MarketSmart to inform shareholders and new investors\nabout the Company’s progress to improve cardiac care worldwide,”\nstated Dr.\n \n \n George Adams, Executive-Chairman of\nVentripoint.\n \n \n “By expanding our outreach\nprogram, we hope to add to our loyal supporters and better reflect the\ntrue value of the Company.”\n \n \n \n \n Adrian Sydenham, President and a Director of\nMarketSmart Communications, stated: \"Ventripoint’s innovative,\nproprietary four-chamber cardiac analysis technology provides the\nmedical community with a more efficient and effective analysis for the\nwhole heart, unlike current methods. Its VMS+3.0 product has market\nauthorizations in Canada, the USA, and the EU and is installed in the\nfirst eleven top hospitals. There is an exponential growing demand for\nthis technology as many Covid-19\n \n \n \n \n patients are experiencing long\nterm adverse health implications of the heart. A fresh injection of\nfunds through warrant exercise has Ventripoint well positioned to\nexecute its corporate objectives. MarketSmart is delighted to have\nbeen awarded the investor relations contract, and we look forward to\ncreating additional awareness in the investment community.”\n \n \n \n \n Pursuant to the IR agreement, MarketSmart will be paid\na fee of $9,500 per month, plus applicable taxes, and will be granted\nstock options to purchase 400,000 common shares of Ventripoint at a\nprice of $0.25 per share ...